Associate Director, International Hta Strategy - Oncology

Job Description
Advances in scientific and technological research are opening up new, promising treatments for previously difficult to treat diseases, increasing the demand on already constrained healthcare budgets. The challenging economic and political environment is leading Health Technology Assessment (HTA) agencies and payers to demand better outcomes at lower cost to overall health system.
To succeed in this environment, we (AbbVie) need to fully understand market value drivers, identify the evidence required for Pricing, Reimbursement and Access (PRA), and work with the evidence generating functions to ensure that evidence generated will support successful HTA outcome and PRA negotiations.
The International HTA Strategy team was established torealize the full value of our assets by strategically informing drug development, evidence generation and HTA submissions, aligned with HTA/payer needs. The primary goals of the function are to ensure HTA evidence requirements are considered early in the development of Abbvie assets and a robust and aligned HTA strategy across the organization in order to ensure the successful launch of Abbvie assets.
Key responsibilities:
Develop HTA insights collaborating with key affiliates to understand Access Evidence requirements for specific diseases and assets
Supports early affiliate engagement (Early Touchpoint process) on behalf of IMAP to help inform (registrational) clinical develop programs
Consult HTA decision Databases, develop HTA /payer engagement plans and gather insights from early scientific advice from HTA agencies and other external experts
Internal stakeholders include:
International Market Access and Pricing;
Global Health Economicsand Outcomes Research;
Affiliates;
Areas;
R&
D;
Commercial;
Medical and Regulatory;
Governance bodies
Support the development of global Payer evidence deliverables, working in close collaboration with global colleagues and external vendors
Support to areas/affiliates on local HTA submissions by providing strategic guidance and coordinating across evidence generation functions at global level (Medical Affairs, HEOR and Clinical Development) to answer questions from HTA agencies